THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.

Similar documents
GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

Contents. Contents (13) 1 Production (23)

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Overview of Regulatory Requirements for API and Formulations

RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EudraLex. Part I1 Chapter 6: Quality Control

San Jose, California, USA

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Registered Starting Material Auditing Guide

Quality Assessment & GMP Similarities & Differences

American Association for Laboratory Accreditation

Good manufacturing practices

SITE MASTER FILE For MHRA

Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines

Prequalification of Medicines Programme

The World Bank. Aide Memoire for use during GMP inspections

Safeguarding public health. Deficiency Database Figures April June 2009

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

CO-ORDINATION OF NOTIFIED BODIES PPE Regulation 2016/425 RECOMMENDATION FOR USE

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

CGMP USP <797> Crosswalk

GMP On Site Series. GMP Essentials

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

EU and FDA GMP Regulations: Overview and Comparison

Documenta tion and Records

18.H Questionnaire for preparing GMP-inspections

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Materials Management Traceability, CEPs and managing non-conforming sites

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. This document is for consultation until 11 December 2015

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART II

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.

AUSTRALIAN CODE OF GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

Drug Good Manufacturing Practices Inspections

Implementation & Documentation Requirements for ISO 22716:2007 Certification

Annex 4. Guidance on good manufacturing practices: inspection report. Background

PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.

Equipment cleaning and use record

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB

Deficiencies found in Inspections and QP Responsibilities

Changes in the EXCiPACT 2017 Edition Requirements from the 2012 Edition

GMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC

CGMP for Phase 1 INDs

Change Control Overview

GMP Track 1 Day 2 Session 1 Vendor Assurance

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Inspections, Compliance, Enforcement, and Criminal Investigations

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Volume 4

Library Guide: Active Pharmaceutical

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Brussels, C(2017) 8179 final. Guidelines

Process development and basic GMP

Self-Evaluation/Audit Checklist for Food Supplement Manufacturers

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Packaging Operations Technical Subcommittee

Prequalification of Medicines Programme

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

UNICEF Quality Assurance in the procurement of medicines

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL

Name of Chapter & Details. Section-I

SECTION 1 GOOD MANUFACTURING PRACTICES (GMP ) AND OTHER FDA GUIDELINES COPYRIGHTED MATERIAL

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

ARAB Guidelines on Current Good Manufacturing Practices (cgmp) for Pharmaceutical Products

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

HACCP audit checklist

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

LABORATORY COMPLIANCE

Responding to an FDA 483

The ABCs and Challenges of GMP The American Experience

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Supplier questionnaire. 1. Organisation Details (Mandatory) Quality Department Details (or representative)

Definitions given below apply to the words as used in this guide. They may have different meanings in other contexts.

Quality and Safety System for Specialty Feed Ingredients PROCESS DOCUMENT FORMULATION PROCESS VERSION

LEARNING, TRAINING, AND PERFORMANCE

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

Vendor Qualification Survey

GENERIC QUALITY ASSURANCE REQUIREMENTS FOR: BUILT TO PRINT ITEMS, ITEMS TO STANDARD AND OFF THE SHELF ITEMS

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

Transcription:

THE GMP HANDBOOK g o o d m a n u fac t u r i n g p r ac t i c e quality systems for the pharmaceutical industry Ke y2 C om pl ia nc e AB by Anna Lundén ANNEXES Key2Compliance AB

Annexes - Content Annexes - Content A Requirements for procedures and records in 4 each respective GMP The symbols at the margins in the chapters of the handbook refer to the specific minimum requirement from the three different GMP texts. These requirements are shown here with referrals to their respective paragraph in the separate GMPs. B Referral to the requirements for verification of a 17 second individual (or equivalent systems) In the different GMP texts there are specific referrals to different forms of verifications or double checks of a second individual that is presented in this annex. C Reference matrix ISO 9001 and GMP-texts 18 In this matrix, the starting point is ISO 9001 and for each section there are references to corresponding requirements in the different GMPs. This matrix can be used as a supporting tool when a comprehensive quality system shall be designed with the ISO principles as a basis. 3

The GMP Handbook quality systems for the pharmaceutical industry Annexes Annex A. Requirements for procedures and records in each respective GMP The symbols at the margins in the chapters refer to the specific minimum requirement from the three different GMP texts. These requirements are shown here with referrals to their respective paragraph in the separate GMPs. EU GMP Guide Part I Requirements Procedures Records Description Identification Managerial/individual responsibilities 1.04, 1.05, 1.07 Chap 2 Principle 2.03 Processing/packaging procedures 1.04, 4.17, 4.18 Release procedure and QP certification 1.04, 4.27 1.04, 1.09, 2.06 Self-Inspection 1.01, 4.29, 9.01 4.29, 9.03 Quality Manual 1.07 Sampling, inspection and testing of starting 1.09, 4.22, 4.25, 1.09, 4.22, 4.26, materials, intermediate, bulk, and finished product 4.26, 6.07, 6.11, 5.38, 6.07, 6.11, 6.12, 6.15, 6.18 6.16, 6.17, 6.18 Environmental/media monitoring 1.9, 4.29 3.19, 4.29, 5.43, 6.07 Product Quality Review 1.10 (according to 4.29) 1.10, 4.29 Ongoing review of corrective and preventive actions 1.04, 1.11 1.04, 1.11 Risk management (procedure not mentioned 1.12 1.12 but may be requested) Organisation chart 2.02 Evaluation of production records of Production 2.07 department Training 2.11, 4.29 2.11, 4.29 6.13 4

2016 Key2Compliance AB Annex A EU GMP Guide Part I (cont.) Requirements Procedures Records Description Identification Personnel hygiene, health, and clothing 2.15, 2.16, 4.29 4.29 Information about consultants 2.23 Premises - cleaning, disinfection and identification Equipment - use, cleaning and identification 3.36, 4.29, 4.30, 5.21 Calibration, maintenance, and checking 3.41, 4.29, 6.07 3.41, 4.29, 4.31, 6.07 3.02, 4.29, 5.21 4.29, 5.21 3.21, 5.12, 5.13 4.29, 4.31, 5.21 3.42, 3.44, 5.12, 5.13 Sanitising of water systems 3.43 Site Master file Chap 4 Principle Computerized systems 4.01 Alterations in documents 4.09 Justification for retirement of records 4.12 Specifications for starting and packaging 4.13, 4.14, 6.07 materials Specifications for finished products 4.13, 4.16, 6.07 Specifications for intermediate and bulk products 4.15, 6.07 Packaging instructions 4.19 Batch processing records 4.20 1.08, 4.20 Batch packaging records 4.21 4.21 Internal labeling 4.24 Distribution records 1.08, 4.28, 8.23 5

The GMP Handbook quality systems for the pharmaceutical industry Annexes EU GMP Guide Part II Requirements Procedures Records Description Identification Rational for point of beginning 1.2 System for quality management 2.11 Persons authorised to release 2.14 Notification to management 2.18 Risk management (procedure not mentioned 2.21 2.21 but may be requested) Responsibilities of quality unit 2.32 Responsibility for production 2.40 Internal audits/self inspection 2.50 2.51 Product quality review 2.60, 2.61 Personnel responsibilities 3.11 Training 3.12 Records on consultants 3.31 Utility systems 4.20 Water quality specifications 4.32 Validation and qualification 4.33, 4.41, 5.40, 4.33, 4.41, 5.40, 5.41, 8.45, 12.10, 5.41, 5.42, 8.45, 12.20, 12.30, 12.22, 12.23, 12.80, 18.51 12.30, 12.80, 12.83, 18.51 Inactivation and cleaning 4.41 Prevention of cross-contamination 4.42 8

2016 Key2Compliance AB Annex A EU GMP Guide Part II (cont.) Requirements Procedures Records Description Identification Sewage and refuse 4.60 Sanitation and cleaning of buildings and facilities 4.71 Use of rodenticides etc. 4.72 Drawings for equipment and installations 5.16 4.23, 7.23 Equipment maintenance 5.20 6.20, 6.21 Cleaning and release of equipment 5.21, 5.25, 19.30 6.20, 6.21 5.26, 8.16 Calibration of equipment 5.30, 19.30 5.32, 6.61 5.33 Changes to data 5.43 Operation and maintenance of computerized systems 5.44 5.46, 5.48 Changes to computerized systems 5.47 5.47 Document control 6.10 2.15 Retention of documents 6.12 Specifications and acceptance criteria 6.17, 7.12, 9.11, 11.13 6.30, 7.13 Equipment cleaning and use record 6.20 Master production records 6.40, 6.41 Handling, storage, test and use of material 6.41, 7.10 6.30 7.23, 7.24 Batch production record 6.50 6.50, 6.52 6.51 Documentation and investigation around deviations 6.53, 11.15 2.16, 5.46, 8.15, and failures 8.20 Batch and control record review 6.70 6.30, 6.60 9

The GMP Handbook quality systems for the pharmaceutical industry Annexes US 21 CFR 211 Key2Compliance Requirements Procedures Records Identification Responsibilities of QCU 211.22(d) Consultants 211.34 Cleaning and sanitation of buildings and facilities 211.56(b) Use of redenticides etc 211.56(c) Cleaning, sanitation, maintenance and inspection of equipment Calibration of equipment 211.68(a), 211.160(b) (4) 211.67(b) 211.67(c ), 211.182 Data back-up 211.68(b) Computer program validation 211.68(b) 211.68(b) Receipt, identification, sampling etc of components, containers and closures 211.80(a), 211.84(c), 211.160(a) 211.68(a), 211.182, 211.194(d) Component specifications 211.84(d)(2) 211.184(b) Containers and closures specifications 211.84(d)(3) & (5), 211.94(d) 211.184(a)&(b) 211.80(d), 211.84(c ), 211.89 Validation of suppliers test results 211.84(d) 211.84(d) Validation of depyrogenation processes 211.94 211.94 Production and process procedures 211.100(a) 211.100(b) Deviation from written procedures 211.100(b) Charge-in of components 211.101 211.101(b) Theoretical and actual yield 211.103 211.103 AB 12

2016 Key2Compliance AB Annex A US 21 CFR 211 (cont.) Requirements Procedures Records Identification Equipment identification 211.105 In-process controls and validation 211.110(a) 211.110(a) In-process specifications 211.110(b) Specifications, standards, sampling plans and testing 211.110(c ), 211.160(a), 211.194(a) 211.160(b) procedures 211.160(a)&(b), 211.165, 211.186(b) Rejected in-process material 211.110(d) Time limits 211.111 211.111 Contamination control 211.113(a) Contamination control, sterile products 211.113(b) Validation of aseptic and sterilization processes 211.113(b) 211.113(b) Reprocessing 211.115(a) Examination of packaging and labeling materials 211.122(a) 211.122(c ), 211.184 (b), 211.184(d) 211.122(d) Reconciliation of labeling 211.125(c) 122.125(e ) Issuance of labeling 211.125(f) Packaging and labeling 211.130 211.130(d)&(e ), 211.184(d) 211.130(b)&(c ) Drug product inspection 211.134(c ) Expiration dating 211.137(c )&(d ) Warehousing 211.142 13

2016 Key2Compliance AB Annex B Annex B. Referral to the requirements for verification of a second individual (or equivalent systems) In the different GMP texts there are specific referrals to different forms of verifications or double checks of a second individual that is presented in this annex. 21CFR210/211 211.67(b)(6) Inspection of equipment 211.101(c) Weighing of drug components 211.101(d) Adding of drug components 211.103 Calculation of yield 211.122(g)(3) Use of cut labeling 211.182 Equipment cleaning and maintenance 211.188(b)(11) Significant steps EU Guide to GMP Part I 4.18(c) Manufacturing equipment checks 4.19(f) Packing equipment checks 4.20(c)&4.21(c) Significant steps, e.g. weighing 5.38 Dispensed material 6.16 Test result calculations 6.17(g) Laboratory test result verification EU Guide to GMP Part II 5.21 Inspection of equipment 5.45 Entering critical data manually in computerized systems 6.52 Critical steps in production 6.60 Laboratory records 8.12 Critical weighing, measuring, or subdividing operations 8.13 Critical activities 9.44 Inspection of packaging and labelling facilities 17

The GMP Handbook quality systems for the pharmaceutical industry Annexes Annex C. Reference matrix ISO 9001 and GMP texts In this annex we have used the structure from ISO 9001:2015 as the base and correlated it to the corresponding requirements in the GMP s. Note that the requirements of the ISOstandard does not have the same degree of detail and not specifically require procedures and ISO 9001 4.4.1; 7.5.1 Requirement description Quality management system established 4.4.1 a, b Determining processes, sequence and their interaction 4.4.1 c,d,e,f Criteria, methods and resources for control of processes 4.4.1 f; Risk management 6.1 4.4.1 g Monitor, measure and analyze processes and act on the results. na Quality manual 4.4.2 Documented procedures and specifications 4.4.2 Records 5.1.1 f Top management shall communicate the importance of quality 5.2.1 ; Quality policy and quality objectives established by management 5.1.1 b; 6.2.1 5.2.2 Quality policy communicated and understood within the organization 18

2016 Key2Compliance AB Annex C records the same way as in the GMP s, but contains general principles for a complete quality management system. Requirements in the ISO standard where there is no equivalent in the GMP s have been omitted (eg requirements related to design and development). EU GMP PART I 21CFR210/211 EU GMP PART II Ch. 1, Principle; 1.1; 1.7 na 2.11; 2.19; 17.30 1.8(i) na 2.12 1.4(i)&(iv) na 2.12 Ch. 1, Principle; na 2.20-21 1.3; 1.12-13 5.20-21; Ch. 8, Principle; Ch. 1, Principle; 1.4(vi); 1.4(viii)&(ix); 1.10; 211.100; 211.180(e); 211.192 2.60; 6.71; 11.15; 15.12 2.8-9; Ch. 4, Principle; 6.2; 6.9; 6.26-36; 7.7 1.7; na na 4.32 Ch. 4, Principle 211.22(c)&(d); 2.12 211.100(a); 211.160(a) Ch. 4, Principle; 4.8 211.180 2.15; 6.14 1.5 na 2.11 Ch. 1, Principle; 2.4 na 2.19 Ch. 1, Principle; 1.5 na 2.10-11 19